17 February 2023
—
Expert views on prostate cancer news from February 2023
Prostate cancer
EM-118240
10 March 2023
—
Evolution and revolution in prostate cancer: what does the future hold?
Janssen sponsored industry session at EAU 2023
Prostate cancer
EM-118258
EM-86801
EM-86762
1 December 2022
- 60 Minutes
That’s a wrap! A review of bladder cancer news in 2022
Bladder cancer~Urothelial cancer
EM-87605
11 November 2022
- 57 Minutes
Controversies in prostate cancer care: Real-world management of patients with mHSPC
Janssen sponsored industry session at EMUC 2022
Prostate cancer
EM-110906
5 October 2022
- 91 Minutes
Exploring questions in metastatic prostate cancer
Janssen sponsored industry session at ESMO 2022
Prostate cancer~september2022updates
EM-106735
5 October 2022
- 88 Minutes
Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Janssen sponsored industry session at ESMO 2022
Lung cancer~september2022updates
EM-106732
21 September 2022
- 59 Minutes
Under the spotlight: A review of recent bladder cancer news from September 2022
Bladder cancer~september2022updates~Urothelial cancer
EM-87601
13 September 2022
- 68 Minutes
An evolving landscape: EGFR-mutant NSCLC management updates from September 2022
Lung cancer~september2022updates
EM-86796